NYU Langone Health

The first iteration of Crisis Point addresses the obesity crisis in the United States and beyond, with expert interviews and discussion.

Episode 4 of Crisis Point asks the question you've been waiting for, "What is blueprint to resolving the obesity crisis?"

Episode 3 of Crisis Point examines the regional differences in obesity, from issues with nutrition and food insecurity to the use of the phrase "food desert".

Episode 2 of HCPLive Crisis Point tackles the clinical aspects and potential burdens clinicians face in the pursuit of obesity care.

HCPLive Crisis Point takes an in-depth look at the obesity crisis, beginning with the process of medical diagnosis and who is impacted the most by the disease.

Esophageal cancer has a low survival rate largely due to advanced stage diagnosis.

Missed diagnosis resulted in delays in initiation of therapy and hospital re-admissions.

Individuals diagnosed with mood or anxiety disorders were not linked to higher COVID-19 mortality.

National Health Center Week kicks off on August 9.

Psilocybin, which is commonly found in psychedelic mushrooms, is linked with enduring antianxiety and antidepressant effects.

Arjun Masurkar, MD, PhD, discusses some of the issues with Alzheimer disease clinical trials.

Arjun Masurkar, MD, PhD, discusses how genetic testing could usher in a new wave of diagnostics for Alzheimer disease.

Lenard Adler, MD, talks about some of the advances in recent years in screening for ADHD in adults and adolescents.

A discussion on why heart failure rates have climbed over the past decade while research indicates rates of cardiovascular disease, as a whole, have begun to decline.

How women's health burdens touch genetics, psychiatry, cardiology, and whether physicians are equipped to manage it all.

Discussing the key differences in the results of ISCHEMIA and ISCHEMIA-CKD, which examined whether the use of invasive or conservative strategies was more effective for patients with ischemic heart disease.

In months, the US may have its first marketed peanut immunotherapies. How will pediatric patient management change?

Discussing why initiatives and policy changes in the fight against obesity and diabetes have been perceived as less successful than those against smoking and educating on cardiovascular diseases.

How PTSD care can be, and should be, individualized for particular patient needs.

Evaluating the impact of DAPA-HF and other recent data that have changed the way cardiologists view the potential uses of SGLT2 inhibitors in patients with or without diabetes.

Discussing how new information released in 2019 has impacted the way cardiologists view aspirin use for primary and secondary prevention of cardiovascular events.

Arjun Masurkar, MD, PhD, previews some of the new medications that could help treat Alzheimer disease, while reviewing some of the advancements of the last decade.

Patient demographics influence difference symptoms, progression, and benefits of care.

How to weigh the 5 agents from the drug class, which have each shown differing benefit in younger patients.

A task force found insufficient evidence on the benefits and harms of screening for lead in asymptomatic children and pregnant persons.

Investigators found readmission risk was 4 times greater in patients with stays of 2 days or less.

As Americans population ages, yet becomes more health conscious, has the average patient suffering from Afib changed in recent years?

How and when do you decide whether to prescribe a patient GLP1 agonists or SGLT2 inhibitors?

How has technology changed the way orthopedic specialists practice and what is driving advances such as minimally invasive spine surgery?

What are some of the future risks, in terms of cardiovascular health, facing the average patient?